advancing innovation to save lives

GHTC welcomes House passage of the Global Health Innovation Act

GHTC welcomes passage by the US House of Representatives of the Global Health Innovation Act (H.R. 1660), a bipartisan bill that will strengthen efforts by the US Agency for International Development to develop lifesaving global health technologies.
Learn More

The first step

GHTC released a new two-minute video taking viewers on a journey to discover how sustained investments in global health R&D can unlock health and opportunity for people around the world.

Member spotlight: Sabin Vaccine Institute

The Sabin Vaccine Institute makes vaccines more accessible, enables innovation and expands immunization across the globe. As a non-profit with more than two decades of experience, Sabin embodies the legacy of its namesake, Dr. Albert B. Sabin, inventor of the oral polio vaccine and lifelong crusader against poverty and preventable disease. Sabin is committed to extending the full benefits of immunization to all people, regardless of who they are or where they live. Sabin has recently welcomed a major grant to spur innovation toward a universal influenza vaccine.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more
Flickr/Helena Peixoto
GHTC statement on the President’s FY 2019 budget

The United States has long led the world in developing vaccines, drugs, diagnostics, and other technologies for neglected diseases and conditions that affect the world’s most vulnerable people, and the President’s budget proposal threatens to undermine this scientific and humanitarian legacy.

Learn More
PATH/Patrick McKern
Washington Post Editorial Board cites GHTC joint letter in opinion

The Washington Post Editorial Board cited a joint-letter co-authored and endorsed by GHTC in an opinion piece calling for the Administration to provide funding to sustain the US Centers for Disease Control and Prevention activities to support he Global Health Security Agenda.

View All News & Events

Member Event

PATH/Gabe Bienczycki
5th Global Forum on TB Vaccines
Stop TB Partnership, Aeras, TBVI, THSTi...
Learn More

Community Event

PATH/Aaron Joel Santos
Research!America 2018 Advocacy Awards Dinner
Learn More
View All Events
Step One

Don Joseph is Chief Operating Officer at BIO Ventures for Global Health (BVGH), a GHTC member, and wrote this blog post in conjunction with the launch of WIPO Re:Search, a new consortium where public and private sector organizations share valuable intellectual property (IP) and expertise with the global health research community to promote development of new drugs, vaccines, and diagnostics to treat neglected tropical diseases, malaria, and tuberculosis.

Read More
What's Ahead on the Hill

In this regular feature on Breakthroughs, Ashley Bennett, senior policy associate at the GHTC, provides an update on what’s currently happening with global health in Congress and an outlook for future legislative activity.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide